Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 4, 2017

Primary Completion Date

May 25, 2018

Study Completion Date

June 30, 2018

Conditions
Vital Sign Monitoring
Interventions
DEVICE

Investigational Group

The RHEA device and Philips Patient Monitor MX400 are used to monitor the heart rate (HR) and respiratory rate (RR) of participants.

DEVICE

reference group-Earlysense system

The reference device Earlysense 2.0 system(vital sign monitoring system) and Philips Patient Monitor MX400 are used to monitor the heart rate (HR) and respiratory rate (RR) of participants.

Trial Locations (3)

20782

Medstar Health Research Institute, Washington D.C.

02111

Tufts Medical Center, Boston

23298-0102

Virginia Commonwealth University, Richmond

Sponsors
All Listed Sponsors
collaborator

Tufts Medical Center

OTHER

collaborator

Medstar Health Research Institute

OTHER

collaborator

Virginia Commonwealth University

OTHER

lead

Darma Inc.

INDUSTRY